AI-Powered Technology by OncoStem

Behind CanAssistBreast

Developed by OncoStem Diagnostics, CanAssistBreast combines patented protein biomarker analysis with clinicopathological parameters and an advanced AI algorithm to generate a personalized breast cancer recurrence risk score for early-stage patients.

OncoStem Diagnostics

Developer of CanAssistBreast and pioneer in AI-powered precision oncology solutions.

Clinical Parameters

  • Tumour Size
  • Tumour Grade
  • Lymph Node Status

AI Algorithm

The AI engine analyses complex interactions between biomarkers and clinical parameters.

Risk Score (0–100)

Generates a personalized recurrence risk score within five years.

Understanding Your Results

What Does Your Risk Score Mean?

CanAssistBreast categorizes patients into low-risk and high-risk groups based on their recurrence score, helping doctors make personalized treatment decisions.

Score ≤ 15.5

Low Risk

Indicates a lower likelihood of breast cancer recurrence within five years.

  • Lower probability of recurrence
  • May avoid unnecessary chemotherapy
  • Reduced treatment-related side effects
  • Supports personalized treatment planning
Score > 15.5

High Risk

Indicates a higher likelihood of recurrence and may require additional treatment strategies.

  • Higher probability of recurrence
  • May benefit from chemotherapy
  • Supports additional treatment planning
  • Helps clinicians make informed decisions
Testing Workflow

How CanAssistBreast Testing Works

From tumour tissue analysis to AI-driven risk prediction, every step is designed to deliver accurate and personalized recurrence risk assessment.

01

Tumour Sample

Tumour tissue collected after surgery is prepared for analysis.

02

Biomarker Testing

Patented protein biomarkers are measured from the tissue sample.

03

Clinical Data

Tumour size, grade and lymph node status are incorporated.

04

AI Analysis

AI evaluates biomarker interactions to calculate recurrence risk.

05

Risk Report

A personalized recurrence score and clinical report are generated.

Report Preview

Comprehensive & Easy-to-Understand Report

The CanAssistBreast report provides a personalized recurrence risk score, clinical interpretation, biomarker analysis, and actionable insights to support informed treatment decisions.

Personalized Risk Score
Clinical Interpretation
Biomarker Summary
Treatment Guidance Support
View Sample Report
CanAssistBreast Report
Take the Next Step

Make Confident Treatment Decisions with CanAssistBreast

Get AI-powered insights into breast cancer recurrence risk and support personalized treatment planning with CanAssistBreast. Download the brochure or connect with our team to learn more.

Book This Test Download Brochure